These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 15809278)

  • 21. Deregulated minichromosomal maintenance protein MCM7 contributes to oncogene driven tumorigenesis.
    Honeycutt KA; Chen Z; Koster MI; Miers M; Nuchtern J; Hicks J; Roop DR; Shohet JM
    Oncogene; 2006 Jul; 25(29):4027-32. PubMed ID: 16518415
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Partners in imprinting: noncoding RNA and polycomb group proteins.
    Wu HA; Bernstein E
    Dev Cell; 2008 Nov; 15(5):637-8. PubMed ID: 19000827
    [TBL] [Abstract][Full Text] [Related]  

  • 23. "Stemness" genomics law governs clinical behavior of human cancer: implications for decision making in disease management.
    Glinsky GV
    J Clin Oncol; 2008 Jun; 26(17):2846-53. PubMed ID: 18539963
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stem cell regulation by polycomb repressors: postponing commitment.
    Pietersen AM; van Lohuizen M
    Curr Opin Cell Biol; 2008 Apr; 20(2):201-7. PubMed ID: 18291635
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of novel tumour-associated genes differentially expressed in the process of squamous cell cancer development.
    Hummerich L; Müller R; Hess J; Kokocinski F; Hahn M; Fürstenberger G; Mauch C; Lichter P; Angel P
    Oncogene; 2006 Jan; 25(1):111-21. PubMed ID: 16247483
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polycomb group complexes self-regulate imprinting of the Polycomb group gene MEDEA in Arabidopsis.
    Jullien PE; Katz A; Oliva M; Ohad N; Berger F
    Curr Biol; 2006 Mar; 16(5):486-92. PubMed ID: 16527743
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aberrant DNA methylation in cutaneous malignancies.
    van Doorn R; Gruis NA; Willemze R; van der Velden PA; Tensen CP
    Semin Oncol; 2005 Oct; 32(5):479-87. PubMed ID: 16210089
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transforming pathways unleashed by a HDAC2 mutation in human cancer.
    Ropero S; Ballestar E; Alaminos M; Arango D; Schwartz S; Esteller M
    Oncogene; 2008 Jun; 27(28):4008-12. PubMed ID: 18264134
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Frequent epigenetic inactivation of Wnt inhibitory factor-1 in human gastrointestinal cancers.
    Taniguchi H; Yamamoto H; Hirata T; Miyamoto N; Oki M; Nosho K; Adachi Y; Endo T; Imai K; Shinomura Y
    Oncogene; 2005 Nov; 24(53):7946-52. PubMed ID: 16007117
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Regulation of immune system by polycomb group genes].
    Ishihara H; Fujisaki S; Miyazaki K; Kanno M
    Tanpakushitsu Kakusan Koso; 2000 Jun; 45(9 Suppl):1633-44. PubMed ID: 10879145
    [No Abstract]   [Full Text] [Related]  

  • 31. [Epigenetic processes in malignant transformation: the role of DNA methylation in cancer development].
    Suijkerbuijk KP; van der Wall E; van Laar T; Vooijs M; van Diest PJ
    Ned Tijdschr Geneeskd; 2007 Apr; 151(16):907-13. PubMed ID: 17500342
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of epigenetic inactivation of 14-3-3sigma in human cancer.
    Lodygin D; Hermeking H
    Cell Res; 2005 Apr; 15(4):237-46. PubMed ID: 15857578
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epigenetic biomarkers for human cancer: the time is now.
    Mulero-Navarro S; Esteller M
    Crit Rev Oncol Hematol; 2008 Oct; 68(1):1-11. PubMed ID: 18430583
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNAs in human cancer: from research to therapy.
    Negrini M; Ferracin M; Sabbioni S; Croce CM
    J Cell Sci; 2007 Jun; 120(Pt 11):1833-40. PubMed ID: 17515481
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of polycomb group proteins in stem cell self-renewal and cancer.
    Gil J; Bernard D; Peters G
    DNA Cell Biol; 2005 Feb; 24(2):117-25. PubMed ID: 15699631
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polycomb group proteins in cell cycle progression and cancer.
    Pasini D; Bracken AP; Helin K
    Cell Cycle; 2004 Apr; 3(4):396-400. PubMed ID: 14752272
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polycomb silencers control cell fate, development and cancer.
    Sparmann A; van Lohuizen M
    Nat Rev Cancer; 2006 Nov; 6(11):846-56. PubMed ID: 17060944
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Molecular biology diagnostics: malignant lymphoid tumors in adults].
    Poulsen CB; Ralfkiaer EM; Borregaard N; Grønboek K
    Ugeskr Laeger; 2003 Feb; 165(9):901-5. PubMed ID: 12661512
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polycomb proteins in hematologic malignancies.
    Martin-Perez D; Piris MA; Sanchez-Beato M
    Blood; 2010 Dec; 116(25):5465-75. PubMed ID: 20716771
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polycomb genes, miRNA, and their deregulation in B-cell malignancies.
    Wang GG; Konze KD; Tao J
    Blood; 2015 Feb; 125(8):1217-25. PubMed ID: 25568352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.